avelumab (Q21083261)
fully human IgG1 anti-PD-L1 monoclonal antibody under investigation for immunotherapy
- MSB0010718C
- anti-PD-L1 mAb
- anti-PD-L1 monoclonal antibody
- Immunoglobulin G1-lambda1, anti-(homo sapiens CD274 (programmed death ligand 1, PDL1, pd-l1, B7 homolog 1, B7H1)), homo sapiens monoclonal antibody
- MSB-0010718C
- Bavencio
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | avelumab |
fully human IgG1 anti-PD-L1 monoclonal antibody under investigation for immunotherapy |
|
Statements
avelumab (English)
0 references
1 reference
8 April 2021
20 July 2017
1 reference
avelumab (English)
3 September 2016
Identifiers
1 reference
avelumab (English)
3 September 2016
1 reference